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The TSM was reliable (alpha  0.70) for all scales. In ad-
dition, patients who experienced post-menopausal bleed-
ing were less satisfied than those who did not experience
post-menopausal bleeding, indicating the preliminary va-
lidity of the TSM. CONCLUSION: The TSM is currently
being used in clinical trials and further research will be
conducted on the predictive validity of the questionnaire
in predicting dropouts from clinical trials. Although the
TSM was developed with women, the questions were
worded in a generic and gender-neutral manner. Thus, it
is intended that the TSM be used and validated in a vari-
ety of trials and conditions.
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OBJECTIVE: Disease-specific questionnaires have often
been used to reflect the gradation of specific disorders.
However, disease-specific questionnaires do not allow
appraisal of clinical outcomes within economic evalua-
tions. Here, a solution could be to determine retrospec-
tive quality of life-weights for health states of disease spe-
cific questionnaires that previously have been used in
trials. The main problem will be to reduce the large num-
ber of health states. We applied this method in the study
of the quality of life effects of Benign Prostatic Hyperpla-
sia (BPH). METHODS: Outcomes of BPH are measured
using the IPSS, which health states can be converted into
quality of life values using time trade-off. For that, a fac-
tor analysis and a decrease of answer levels are needed to
reduce the number of health states to be valued. RE-
SULTS: After factor analysis two main factors remain,
namely “obstructive” (alpha  0.8018) and “irritative”
(alpha  0.7165). Each of these factors identified by fac-
tor analysis was described at three levels in order to re-
strict the number of possible health states. The resulting
9 health states were valued by the general public. The
quality of life values range from 0.8330 for the worst
BPH-state to 0.9599 for the best BPH-state. The domain
irritative appeared to be experienced as more “severe”
than the domain obstructive. CONCLUSION: The study
shows that by using a factor analysis the large number of
health states can be reduced, which offers the possibility
to convert disease-specific outcomes into utilities. The
study also shows that the two different domains of BPH
(obstructive and irritative) have a different impact on the
quality of life values. Because the IPSS is now validated
for the use in economic appraisal, new and already pub-
lished research can be used to determine the cost per
QALY of different interventions in BPH.
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OBJECTIVE: To explore the differences among missing
data imputation methods when comparing treatment op-
tions. METHODS: Data from a randomized clinical trial
evaluating the effects of treatment on asthma quality of
life (QOL) were obtained. The instrument employed to
measure QOL was the Asthma Quality of Life Question-
naire. Six common statistical techniques for handling
missing data were evaluated: Complete case analysis
(CCA), Markov modeling, hot deck, general imputation
(GI), last value carried forward (LVCF), and regression.
Scores in the tenth week were modeled using ANCOVA
with the baseline score as the covariate. RESULTS: A to-
tal of 303 subjects were available for analysis, however
only 134 subjects had data available for CCA. Two of
the three treatment groups had 100 subjects while the re-
maining treatment group had 103 subjects. Overall LVCF
had the lowest average score (5.37, 	  1.03), indicating
lower quality of life, whereas CCA produced the highest
average score (5.83, 	  0.84). The effect of treatment
group was found to be statistically insignificant across all
six methods; however, the LVCF method (P  0.1667)
and the GI method (P  0.1227) were substantial closer
to achieving statistical significance than other methods.
CONCLUSIONS: Differing imputation methods did not
affect the decision of the analysis. CCA produced the
highest average imputation scores while LVCF produced
the lowest average imputation scores.
Table 1. AQLQ Scores at the Tenth Week Utilizing 
Different Imputation Methods
Imputation 
Method
Treatment
1
Treatment
2
Treatment 
3 Overall
Significance 
of
Treatment
Group
CCA 
(n  134) 5.84 (0.91) 5.68 (0.93) 5.95 (0.63) 5.83 (0.84) 0.228
Markov 
Model 5.71 (0.92) 5.82 (0.87) 5.85 (0.82) 5.80 (0.87) 0.367
Hot Deck 5.74 (0.91) 5.82 (0.91) 5.88 (0.71) 5.82 (0.84) 0.449
GI 5.62 (1.00) 5.53 (0.98) 5.76 (0.74) 5.64 (0.92) 0.123
LVCF 5.42 (1.06) 5.23 (1.10) 5.47 (0.93) 5.37 (1.03) 0.168
Regression 5.69 (0.83) 5.76 (0.77) 5.82 (0.63) 5.76 (0.74) 0.362
